IQVIA Posts 3Q EPS of $2.10 as Shares Sit Near 52-Week High
IQV sits 82% above its 52-week low of $154.5.
Summary
IQVIA reported third-quarter EPS of $2.10, alongside adjusted EPS of $3.34, net income of $350M and revenue of $4.43B. The print lands with the stock at $280.51, just below its 52-week high of $282.98, so expectations were already elevated. For reference, Q2 adjusted EPS came in at $3.15 on revenue of $4.37 billion, above the high end of guidance, with backlog at $34.2 billion. The company raised full-year 2026 guidance to revenue of $17.35B-$17.5B, Adjusted EBITDA of $4.025B-$4.055B and Adjusted Diluted EPS of $12.90-$13.00. The $2.0 billion senior notes refinancing completed in September is already behind the company and does not change the operating picture here.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — IQVIA raised full-year 2026 guidance to revenue of $17.35B-$17.5B, Adjusted EBITDA of $4.025B-$4.055B and Adjusted Diluted EPS of $12.90-$13.00.
At the time of this announcement, IQV was trading at $280.51 on NYSE in the Life Sciences sector, with a market capitalization of approximately $45B. The 52-week trading range was $154.50 to $282.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.